Viking Global Opportunities Portfolio GP LLC

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Sio Gene Therapies Inc. · on record since Jul 13, 2016
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Glori Energy Inc. · on record since Jun 7, 2024
10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at FIGS, Inc. · on record since Jun 7, 2021
10% owner at GENENTECH INC · on record since Sep 23, 2021
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
10% owner at ADAPTEC INC · on record since Jun 26, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at · on record since Jul 12, 2019
10% owner at · on record since Apr 28, 2020
10% owner at · on record since Apr 8, 2020
10% owner at · on record since Aug 28, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Dec 17, 2020
10% owner at · on record since Sep 21, 2021
10% owner at · on record since Oct 1, 2021
10% owner at · on record since Jan 13, 2022
10% owner at · on record since Nov 25, 2022

Insider trading activity of Viking Global Opportunities Portfolio GP LLC

Transactions on record: 5; since Oct 17, 2017

Open-market buys: 4; $10.2M

Open-market sells: 0

Companies traded: 3; last filing Jun 11, 2019

Figures computed from official regulatory filings — .

Companies where Viking Global Opportunities Portfolio GP LLC has traded

3 tx · $177.3K · Jun 11, 2019
1 tx · $10M · Mar 19, 2019
1 tx · $50M · Oct 17, 2017

Track record of Viking Global Opportunities Portfolio GP LLC

Statistical track record

Free

Open-market buys: 5

Last buy: Jun 11, 2019

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Viking Global Opportunities Portfolio GP LLC

Co-insiders of Viking Global Opportunities Portfolio GP LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Urovant Sciences Ltd.	Jun 11, 2019	Buy	7,500	8.35 USD	$62.6K	SEC
Urovant Sciences Ltd.	Jun 11, 2019	Buy	7,189	8.58 USD	$61.7K	SEC
Urovant Sciences Ltd.	Jun 11, 2019	Buy	6,649	7.97 USD	$53K	SEC
Sio Gene Therapies Inc.	Mar 19, 2019	Buy	6,666,667	1.50 USD	$10M	SEC
Arbutus Biopharma Corp	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Urovant Sciences Ltd.	Jun 11, 2019	Buy	7,500	8.35 USD	$62.6K	SEC
Urovant Sciences Ltd.	Jun 11, 2019	Buy	7,189	8.58 USD	$61.7K	SEC
Urovant Sciences Ltd.	Jun 11, 2019	Buy	6,649	7.97 USD	$53K	SEC
Sio Gene Therapies Inc.	Mar 19, 2019	Buy	6,666,667	1.50 USD	$10M	SEC
Arbutus Biopharma Corp	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	SEC